Minute Sweatcontrol News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Minute Sweatcontrol. Real-time updates on events, politics, business and more.

Candesant Biomedical Announces $35M in Series B Financing to Advance Commercialization of Brella™, the First and Only FDA-cleared 3-Minute SweatControl Patch™

June 6, 2023

/PRNewswire/ -- Candesant Biomedical, Inc. ("Candesant"), a private medical device company focused on the development and commercialization of non-invasive...

United States Suzanne Haber Candesant Biomedical Inc Prnewswire Candesant Biomedical Inc Brella Early Experience Program Consumer Survey On Cosmetic Dermatologic Procedures

Source: prnewswire.com

FDA Clears Patch Therapy to Reduce Excessive Underarm Sweating in Adults

April 15, 2023

The FDA has cleared Brella 3-Minute SweatControl Patch to reduce excessive underarm sweating in adults with primary axillary hyperhidrosis.

Drug Administration Candesant Brella Early Experience Program Minute Sweat Control Hyperhidrosis Disease Severity Scale Niquette Hunt Minute Sweatcontrol

Source: clinicaladvisor.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Minute Sweatcontrol News Today

Candesant Biomedical Announces $35M in Series B Financing to Advance Commercialization of Brella&#x2122;, the First and Only FDA-cleared 3-Minute SweatControl Patch&#x2122;

FDA Clears Patch Therapy to Reduce Excessive Underarm Sweating in Adults

Explore More Categories

Candesant Biomedical Announces $35M in Series B Financing to Advance Commercialization of Brella™, the First and Only FDA-cleared 3-Minute SweatControl Patch™